PTF1A增强子突变所致糖尿病患者的临床特征与长期随访
该研究在12个三级儿童内分泌中心随访30例PTF1A增强子突变所致糖尿病患者,中位随访4年。患者多表现为出生后不久起病糖尿病、胰腺外分泌功能不全,并常见一过性铁蛋白升高、贫血、胆汁淤积及生长迟缓。研究扩大了该病的表型谱,提示胰腺外特征可能反映长期肠道吸收不良。
要点
- PTF1A增强子突变患者常于出生后不久发生糖尿病,多数在6月龄前确诊。
- 所有患者均存在胰腺外分泌功能不全,长期随访可见生长迟缓。
- 常见一过性铁蛋白升高、贫血和胆汁淤积,可能反映长期肠道吸收不良。
核心结论
- PTF1A增强子突变所致糖尿病具有独特的临床表型,包括新生儿期起病糖尿病、胰腺外分泌功能不全及多种胰腺外特征。
- 长期随访发现生长迟缓常见,部分患者出现轻度发育迟缓。
- 反复出现的胰腺外特征可能反映长期肠道吸收不良。
研究设计与样本
- 多中心回顾性/前瞻性随访研究,纳入12个三级儿童内分泌中心的30例PTF1A增强子突变所致糖尿病患者。
- 中位随访时间为4年。
主要发现
- 共鉴定出5种不同的纯合突变,最常见为Chr10:g.23508437A>G(n=18),2例为新的Chr10:g.23508336A>G纯合突变。
- 出生体重中位SDS为-3.4,糖尿病诊断中位年龄为5天,仅2/30在6月龄后起病。
- 所有患者均有胰腺外分泌功能不全;长期随访中5例有发育迟缓(4例轻度)。
- 一过性铁蛋白升高12/12例(检测者中),贫血19/25例,胆汁淤积14/24例。
- 出生后生长受损,身高中位SDS为-2.35,BMI中位SDS为-0.52,20/29(69%)例有生长迟缓。
临床怎么用
- 对新生儿期起病的糖尿病患者,应警惕PTF1A增强子突变,并评估胰腺外分泌功能。
- 长期随访中需监测生长、血常规、铁蛋白及肝功能,关注肠道吸收不良相关表现。
局限性
- 样本量较小(30例),随访时间中位4年,部分指标检测例数不全。
- 为多中心描述性研究,未设对照组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Biallelic mutations in the PTF1A enhancer are the commonest cause of isolated pancreatic agenesis. These patients do not have severe neurological features associated with loss-of-function PTF1A mutations. Their clinical phenotype and disease progression have not been well characterized. OBJECTIVE: To evaluate phenotype and genotype characteristics and long-term follow-up of patients with PTF1A enhancer mutations. SETTING: Twelve tertiary pediatric endocrine referral centers. PATIENTS: Thirty patients with diabetes caused by PTF1A enhancer mutations. Median follow-up duration was 4 years. MAIN OUTCOME MEASURES: Presenting and follow-up clinical (birthweight, gestational age, symptoms, auxology) and biochemical (pancreatic endocrine and exocrine functions, liver function, glycated hemoglobin) characteristics, pancreas imaging, and genetic analysis. RESULTS: Five different homozygous mutations affecting conserved nucleotides in the PTF1A distal enhancer were identified. The commonest was the Chr10:g.23508437A>G mutation (n = 18). Two patients were homozygous for the novel Chr10:g.23508336A>G mutation. Birthweight was often low (median SDS = -3.4). The majority of patients presented with diabetes soon after birth (median age of diagnosis: 5 days). Only 2/30 presented after 6 months of age. All patients had exocrine pancreatic insufficiency. Five had developmental delay (4 mild) on long-term follow-up. Previously undescribed common features in our cohort were transiently elevated ferritin level (n = 12/12 tested), anemia (19/25), and cholestasis (14/24). Postnatal growth was impaired (median height SDS: -2.35, median BMI SDS: -0.52 SDS) with 20/29 (69%) cases having growth retardation. CONCLUSION: We report the largest series of patients with diabetes caused by PTF1A enhancer mutations. Our results expand the disease phenotype, identifying recurrent extrapancreatic features which likely reflect long-term intestinal malabsorption.
引用
- Demirbilek H, Cayir A, Flanagan SE, et al. Clinical Characteristics and Long-term Follow-up of Patients with Diabetes Due To PTF1A Enhancer Mutations. J Clin Endocrinol Metab. 2020. PMID: 32893856. doi:10.1210/clinem/dgaa613
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。